1. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers;Anandasabapathy;Bone Marrow Transplant.,2015
2. Abstract 9589: A phase II randomized study of CDX-1401, a dendritic cell targeting NY-ESO-1 vaccine, in patients with malignant melanoma pre-treated with recombinant CDX-301, a recombinant human Flt3 ligand;Bhardwaj;J. Clin. Oncol.,2016
3. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting Cancer immune control;Bottcher;Cell,2018
4. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity;Broz;Cancer Cell,2014
5. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells;Cheng;Cell,2021